The timelines for the price and reimbursement authorization in Italy 2018–2020

OBJECTIVE: This investigation aimed to guarantee the principles of transparency in public administration; to inform citizens about the time to patient access to reimbursed medicines; to assess the duration of the P&R process for the first time in the period 2018–2020; and to evaluate whether and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Valentina, Alessi, Eva, Montilla, Simona, Altamura, Gianluca, Traversa, Giuseppe, Trotta, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810802/
https://www.ncbi.nlm.nih.gov/pubmed/36619645
http://dx.doi.org/10.3389/fmed.2022.1055359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810802/
https://www.ncbi.nlm.nih.gov/pubmed/36619645
http://dx.doi.org/10.3389/fmed.2022.1055359

Ejemplares similares